cn3
Wednesday, 22 March 2017
Rare Discovery: A Value in the Biotech World
Falling hepatitis C revenue has dented giants such as AbbVie and Gilead but created a rare bargain in biotech Enanta
from WSJ.com: Markets http://ift.tt/2mQKINm
via https://ifttt.com/ IFTTT
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment